IP vs SLRX
International Paper (IP) versus Salarius Pharmaceuticals Inc (SLRX) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
IP does not have a complete income-statement cache yet.
Latest reported SLRX revenue for 2023-03-31 was $0. Net income was -$5.3M. SLRX currently screens at market cap $4.9M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. SLRX currently screens at market cap $4.9M.
Not investment advice. Open the IP and SLRX stock pages for the full models.
Not investment advice.